Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples

Transfusion

Volumn 53, Issue 10 PART 2, 2013, Pages 2575-2584

  Maple, Peter A C ^a   Beard, Stuart ^a   Parry, Ruth P ^a   Brown, Kevin E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANIMAL; ARTICLE; BLOOD; BLOOD DONOR; EPIDEMIOLOGY; FLUOROIMMUNOASSAY; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PARVOVIRUS; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; SF9 CELL; UNITED KINGDOM; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT; PARVOVIRIDAE; PARVOVIRIDAE INFECTIONS; PROCEDURES; SF9 CELL LINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, VIRAL; BLOOD DONORS; BLOTTING, WESTERN; FLUOROIMMUNOASSAY; GREAT BRITAIN; HUMANS; MASS SCREENING; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; SF9 CELLS; YOUNG ADULT;

EID: 84891680167     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12278     Document Type: Article

References (27)

1. Brown KE. The expanding range of parvoviruses which infect humans. Rev Med Virol 2010;20:231-44.
2. Tse H, Tsoi H-W, Teng JLL, Chen X-C, Liu H, Zhou B, Zheng B-J, Woo PCY, Lau SKP, Yuen K-Y. Discovery and genomic characterization of a novel ovine partetravirus and a new genotype of bovine partetravirus. PloS ONE 2011;6:e25619.
3. Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 2005;79:8230-6.
4. Li B, Ma J, Xiao S, Wen L, Ni Y, Zhang X, Fang L, He K. Genome sequence of a highly prevalent porcine partetravirus in mainland China. J Virol 2012;86:1899.
5. Sharp CP, Lail A, Donfield S, Gomperts ED, Simmonds P. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion 2012;52:1482-9.
6. Fryer JE, Delwart E, Hecht FM, Bernardin F, Jones MS, Shah N, Baylis SA. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 2007;47: 1054-61.
7. Delwart E. Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter? Transfusion 2012;52:1398-403.
8. Simmonds P, Manning A, Kenneil R, Carnie FW, Bell JE. Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis 2007;13:1386-8.
9. Yu X, Zhang J, Hong L, Wang J, Yuan Z, Zhang X, Ghildyal R. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in Shanghai. Plos ONE 2012;7:e29474.
10. Sharp CP, Lail A, Donfield S, Simmons R, Leen C, Klenerman P, Delwart E, Gomperts ED, Simmonds P. High frequencies of exposure to the novel human parvovirus PARV4 in haemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis 2009;200:1119-25.
11. Lahtinen A, Kivela P, Hedman L, Kumar A, Kantele A, Lappalainen M, Liitsola K, Ristola M, Delwart E, Sharp C, Simmonds P, Soderlund-Venermo M, Hedman K. Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis 2011;17:79-82.
12. Panning M, Kobbe R, Vollbach S, Drexler JF, Adjei S, Adjei O, Drosten C, May J, Eis-Hubinger AM. Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis 2010;16:1143-6.
13. Sharp CP, Vermeulen M, Nebie Y, Djoko C, LeBreton M, Tamoufe U, Rimoin AW, Kayembe PK, Carr JK, Servant-Delmas A, Laperche S, Harrison GLA, Pybus OG, Delwart E, Wolfe ND, Saville A, Lefrere J-J, Simmonds P. Epidemiology of human parvovirus 4 infection in Sub-Saharan Africa. Emerg Infect Dis 2010;16:1605-7.
14. McKie A, Vyse A, Maple C. Novel methods for the detection of microbial antibodies in oral fluid. Lancet Infect Dis 2002;2:18-24.
15. Lou S, Xu B, Huang Q, Zhi N, Cheng F, Wong S, Brown K, Delwart E, Liu Z, Qiu J. Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae. Virology 2012;422:59-69.
16. Casal JI, Rueda P, Hurtado A. Parvovirus-like particles as vaccine vectors. Methods 1999;19:174-86.
17. Tuke PW, Parry RP, Appleton H. Parvovirus PARV4 visualization and detection. J Gen Virol 2010;91:541-4.
18. Maple PAC, Breuer J, Quinlivan M, Kakatos G, Brown KE. Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers. J Clin Virol 2012;53:201-7.
19. Gay NJ. Analysis of serological surveys using mixture models: application to a survey of parvovirus B19. Stat Med 1996;15:1567-73.
20. Baughman AL, Bisgard KM, Lynn F, Meade BD. Mixture model analysis for establishing a diagnostic cut-off point for pertussis antibody levels. Stat Med 2006;25: 2994-3010.
21. Touinssi M, Brisbarre N, Picard C, Frassati C, Dussol B, Uch R, Gallian P, Cantaloube JF, Micco Pd, Biagini P. Parvovirus 4 in blood donors, France. Emerg Infect Dis 2010; 16:165-6.
22. Yang S-J, Hung C-C, Chang S-Y, Lee K-L, Chen M-Y. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection. J Clin Virol 2011;51:64-7.
23. Lavoie M, Sharp CP, Pepin J, Pennington C, Foupouapouognigni Y, Pybus OG, Njouom R, Simmonds P. Human parvovirus 4 infection, Cameroon. Emerg Infect Dis 2012; 18:680-3.
24. Gay NJ, Hesketh LM, Cohen BJ, Rush M, Bates C, Morgan-Capner P, Miller E. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy. Commun Dis Rep CDR Rev 1994;4:R104-107.
25. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England andWales. J Med Microbiol 1988;25:151-3.
26. Brown KE, Simmonds P. Parvoviruses and blood transfusion. Transfusion 2007;47:1745-50.
27. Manning A, Willey SJ, Bell JE, Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 2007;195: 1345-52.